Coming Soon

Season 1: Network Effects
Unlock exponential growth
Master the 16 network effects
20 years of insights in one class
Investor List:

Top Medical Devices Series B Investors in Midwest (44)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Medical Devices investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Jan Garfinkle, Managing Director at Arboretum Ventures
Jan Garfinkle
Arboretum Ventures·Managing Director
Sweet spot: $10.0M
Range: $10.0M - $15.0M
Investors in Detroit (MI)
Investors in Diverse Investors (Other Lists), Investors in Female Investors (Other Lists), Investors in Health IT, Investors in Health IT, Investors in Medical Devices, Investors in Medical Devices
Photo of Brian Kornmann, Managing Director at Thompson Street Capital Partners
Brian Kornmann
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in BioTech, Investors in Consumer Health, Investors in Consumer Internet, Investors in Digital Health, Investors in Enterprise Applications, Investors in Enterprise, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Midwest (Other Lists), Investors in Pharmaceuticals
Photo of Bob Dunn, Managing Partner at Thompson Street Capital Partners
Bob Dunn
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in BioTech, Investors in Consumer Health, Investors in Consumer Internet, Investors in Digital Health, Investors in Enterprise Infrastructure, Investors in Enterprise, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Midwest (Other Lists), Investors in Pharmaceuticals
Photo of Jack Senneff, Managing Director at Thompson Street Capital Partners
Jack Senneff
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in Enterprise Infrastructure, Investors in Enterprise, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Midwest (Other Lists), Investors in Pharmaceuticals
Photo of Mark McDonnell, Managing Director at ARCH Venture Partners
Mark McDonnell
ARCH Venture Partners·Managing Director
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Chicago (IL)
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Midwest (Other Lists), Investors in Pharmaceuticals
Photo of Jeff Aiello, Managing Director at Thompson Street Capital Partners
Jeff Aiello
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in AI, Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in Enterprise Applications, Investors in Enterprise Infrastructure, Investors in Enterprise, Investors in Health IT, Investors in Medical Devices, Investors in Midwest (Other Lists), Investors in Pharmaceuticals
Photo of Ray Wagner, Managing Director at Thompson Street Capital Partners
Ray Wagner
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in AI, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Internet, Investors in Digital Health, Investors in Enterprise, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Midwest (Other Lists), Investors in Pharmaceuticals
Photo of Rick Clifton, Managing Director at Thompson Street Capital Partners
Rick Clifton
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in AI, Investors in BioTech, Investors in ClimateTech/CleanTech, Investors in Consumer Health, Investors in Digital Health, Investors in Enterprise, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Midwest (Other Lists), Investors in Pharmaceuticals
Get new data & insights delivered to your inbox